The genetic information is encrypted in the DNA. However, expression of protein is mainly controlled by histone proteins and their modifications, the so-called “epigenetics”. Studies found that over 50% of cancerous diseases show epigenetic mutations. More than that, cancer cells use epigenetic modifications to evade classic chemotherapy. Thus, the development of new pharmaceuticals that target the epigenome becomes increasingly important in the fight against cancer, but also in other genetic diseases/disorders.
However, identifying crucial modifications has been very time consuming and required high quantities of cellular examination material.
The team of EpiQMAx combines excellence in biochemistry and bioinformatics to tackle this challenge with a fast and highly sensitive solution. They use a unique KIT for probe preparation and mass spectrometry to minimize the number of cells needed and analyze and visualize the data obtained to empower their clients in the fight against (epi)genetic diseases.
Meet them at our StartUp-Event to learn more about their solution, get to know the team and to find out how their approach improves the fight against cancer and other (epi)genetic diseases.
After the presentation, we will discuss the topic within our interdisciplinary health hacker community (physicians, caregivers, engineers, programmers, students, and hackers).
This event is part of the lecture “New technologies and methods for the future of healthcare”.
18:30 – 18:45 Opening and introduction
18:45 – 19:45 Pitch, demo and Q&A
19:45 – 20:45 General discussion
after 20:45 Drinks & Chat
*The talk and discussion might be in English or German depending on audience and speakers
Everyone is welcome to join this event and bring their friends!
We are looking forward to meeting you!